(NUVA) Noratis - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000A2E4MK4

NUVA: Residential, Apartments, Retail, Properties, Housing, Estates

Noratis AG, a German real estate company, specializes in the acquisition, development, management, and sale of residential property portfolios. Its primary focus is on multi-family housing, including apartments, residential areas, and housing estates. The company also maintains a smaller portfolio of retail store properties. Established in 2002 and headquartered in Eschborn, Germany, Noratis AG operates within the German real estate market, targeting undervalued properties for redevelopment and value enhancement. The companys strategy emphasizes medium-term property holding periods, with a focus on generating returns through active asset management and market-driven sales strategies.

From a technical perspective, the stock exhibits bearish momentum. The last price of 1.24 is below the SMA 20 (1.40) and SMA 50 (1.53), indicating downward pressure. The SMA 200 at 2.34 further confirms the stocks decline over the past year. The ATR of 0.07 reflects low volatility, suggesting limited near-term price movement.

Fundamentally, Noratis AG faces challenges in profitability, as evidenced by a negative RoE of -47.23. The companys low P/B ratio of 0.29 and P/S ratio of 0.40 suggest undervaluation relative to its book value and revenue. However, the forward P/E of 8.00 indicates market expectations for improved earnings. The companys market cap of 19.14M EUR reflects its smaller size within the real estate sector.

3-Month Forecast: Based on , the stock is likely to remain under pressure, with potential resistance at the SMA 20 (1.40) and SMA 50 (1.53). The low ATR suggests limited upside or downside movement. From a perspective, the companys ability to improve profitability will be critical. If earnings align with the forward P/E expectations, the stock could see stabilization or modest recovery. However, the negative RoE and low trading volume may limit near-term upside.

Additional Sources for NUVA Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

NUVA Stock Overview

Market Cap in USD 14m
Sector Real Estate
Industry Real Estate - Development
GiC Sub-Industry Real Estate Operating Companies
IPO / Inception

NUVA Stock Ratings

Growth Rating -93.8
Fundamental 2.73
Dividend Rating 1.0
Rel. Strength -84.1
Analysts -
Fair Price Momentum 0.60 EUR
Fair Price DCF 36.90 EUR

NUVA Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y -100.00%
Payout Consistency 43.7%

NUVA Growth Ratios

Growth Correlation 3m -94%
Growth Correlation 12m -90.5%
Growth Correlation 5y -87.6%
CAGR 5y -44.77%
CAGR/Max DD 5y -0.47
Sharpe Ratio 12m -0.05
Alpha -87.21
Beta 0.219
Volatility 205.40%
Current Volume 3.1k
Average Volume 20d 2.2k
What is the price of NUVA stocks?
As of April 12, 2025, the stock is trading at EUR 0.89 with a total of 3,100 shares traded.
Over the past week, the price has changed by +10.62%, over one month by -17.29%, over three months by -53.17% and over the past year by -82.98%.
Is Noratis a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Noratis is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 2.73 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NUVA as of April 2025 is 0.60. This means that NUVA is currently overvalued and has a potential downside of -32.58%.
Is NUVA a buy, sell or hold?
Noratis has no consensus analysts rating.
What are the forecast for NUVA stock price target?
According to ValueRays Forecast Model, NUVA Noratis will be worth about 0.7 in April 2026. The stock is currently trading at 0.89. This means that the stock has a potential downside of -26.97%.
Issuer Forecast Upside
Wallstreet Target Price 1.1 23.6%
Analysts Target Price - -
ValueRay Target Price 0.7 -27%